A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.

We demonstrate here a rapid alternative method for the production of functional bi-specific antibodies using the mild reducing agent 2-mercaptoethanesulfonic acid sodium salt (MESNA). Following reduction of a mixture of two monoclonal antibodies with MESNA to break inter heavy chain bonds, this solu...

Full description

Bibliographic Details
Main Authors: Jennifer Carlring, Evy De Leenheer, Andrew William Heath
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3141073?pdf=render
id doaj-6607d53e3c1e44dda470eaf339710ceb
record_format Article
spelling doaj-6607d53e3c1e44dda470eaf339710ceb2020-11-25T02:16:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0167e2253310.1371/journal.pone.0022533A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.Jennifer CarlringEvy De LeenheerAndrew William HeathWe demonstrate here a rapid alternative method for the production of functional bi-specific antibodies using the mild reducing agent 2-mercaptoethanesulfonic acid sodium salt (MESNA). Following reduction of a mixture of two monoclonal antibodies with MESNA to break inter heavy chain bonds, this solution is dialysed under oxidising conditions and antibodies are allowed to reform. During this reaction a mixture of antibodies is formed, including parental antibodies and bi-specific antibody. Bi-specific antibodies are purified over two sequential affinity columns. Following purification, bi-specificity of antibodies is determined in enzyme-linked immunosorbent assays and by flow cytometry. Using this redox method we have been successful in producing hybrid and same-species bi-specific antibodies in a time frame of 6-10 working days, making this production method a time saving alternative to the time-consuming traditional heterohybridoma technology for the production of bi-specific antibodies for use in early pilot studies. The use of both rat and mouse IgG antibodies forming a rat/mouse bi-specific antibody as well as producing a pure mouse bi-specific antibody and a pure rat bi-specific antibody demonstrates the flexibility of this production method.http://europepmc.org/articles/PMC3141073?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Jennifer Carlring
Evy De Leenheer
Andrew William Heath
spellingShingle Jennifer Carlring
Evy De Leenheer
Andrew William Heath
A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
PLoS ONE
author_facet Jennifer Carlring
Evy De Leenheer
Andrew William Heath
author_sort Jennifer Carlring
title A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
title_short A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
title_full A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
title_fullStr A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
title_full_unstemmed A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
title_sort novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description We demonstrate here a rapid alternative method for the production of functional bi-specific antibodies using the mild reducing agent 2-mercaptoethanesulfonic acid sodium salt (MESNA). Following reduction of a mixture of two monoclonal antibodies with MESNA to break inter heavy chain bonds, this solution is dialysed under oxidising conditions and antibodies are allowed to reform. During this reaction a mixture of antibodies is formed, including parental antibodies and bi-specific antibody. Bi-specific antibodies are purified over two sequential affinity columns. Following purification, bi-specificity of antibodies is determined in enzyme-linked immunosorbent assays and by flow cytometry. Using this redox method we have been successful in producing hybrid and same-species bi-specific antibodies in a time frame of 6-10 working days, making this production method a time saving alternative to the time-consuming traditional heterohybridoma technology for the production of bi-specific antibodies for use in early pilot studies. The use of both rat and mouse IgG antibodies forming a rat/mouse bi-specific antibody as well as producing a pure mouse bi-specific antibody and a pure rat bi-specific antibody demonstrates the flexibility of this production method.
url http://europepmc.org/articles/PMC3141073?pdf=render
work_keys_str_mv AT jennifercarlring anovelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies
AT evydeleenheer anovelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies
AT andrewwilliamheath anovelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies
AT jennifercarlring novelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies
AT evydeleenheer novelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies
AT andrewwilliamheath novelredoxmethodforrapidproductionoffunctionalbispecificantibodiesforuseinearlypilotstudies
_version_ 1724893465638076416